Berkeley Lights
lights cell line development platform can address industry bottlenecks in manufacturing | Berkeley Lights
Company
Deck Type
Sector
Industry
Deck date
November 2022
Slide
57 of 91
Related slides by other companies
MaxCyte
Investor Presentation
January 2024
| MaxCyte
Alkermes
Investor Day
March 2021
tumor targeted split advancing toward preclinical proof of concept and cell line development engineer tumor targeted subunits fused to proprietary tumor targeting antibody demonstrate that tumor targeted subunits are retained in tumors with expected kinetics demonstrate that sequentially administered subunits combine to form functional and drive dose dependent production in humanized mice complete humanization of tumor targeting antibodies ongoing characterize lead candidates and preclinical proof of concept studies planned initiate cell line development | Alkermes
MaxCyte
Results
November 2023
| MaxCyte
Absci
Investor Presentation
March 2023
specialized coli cell lines | Absci
Other recent decks by Berkeley Lights
See all presentations (7 decks)
Investor Presentation
May 2023
Investor Conference
January 2023
Mergers and Acquisitions
December 2022
Investor Conference
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io